WebDec 13, 2024 · skin itching, rash, or redness stomach fullness swelling of the face, throat, or tongue vomiting yellow eyes or skin Incidence not known Anxiety bloating blurred vision … WebRepatha can cause serious side effects including, serious allergic reactions. Stop taking Repatha and call your healthcare provider or seek emergency help right away if you have any of these symptoms: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.
Repatha injection: Side effects, cost, dosage, generic, and …
hives, itching, or rash; large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals; nausea; reddening of the skin, especially around the ears; swelling of the eyes, face, or inside of the nose; unusual tiredness or weakness; Other side effects of Repatha See more Along with its needed effects, evolocumab (the active ingredient contained in Repatha) may cause some unwanted effects. Although not … See more Some side effects of evolocumab may occur that usually do not need medical attention. These side effects may go away during treatment as … See more Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. … See more flippingfifty.com
FDA Approves Amgen
WebApr 11, 2024 · Evolocumab (Repatha) PCSK9 inhibitors are usually reserved for people who cannot tolerate statins or who have familial hypercholesterolemia, a genetic condition that causes high levels of LDL cholesterol. They are administered as injections and can cause side effects such as redness, itching, and swelling at the injection site. WebOct 2, 2024 · Flu, dizziness, and abdominal pain. Besides side effects as above, repatha side effects also have a serious and dangerous. So, tell your doctor if you experience any effects and reactions like allergy signs. These allergic signs can include itching, severe itching, chest tightness, difficulty in breathing, swelling of the lips, tongue, and throat. WebThe therapy was then changed to subcutaneous injection of 420 mg evolocumab monthly. A few days after the first dose, the patient experienced pruritus and rash on his … greatest showman from now on